Novo Nordisk - Worst Performing Pharmaceutical

The market ended the tradingsessionlower with the S&P 500 losing 0.75%. Stocks of Pharmaceutical Companies also traded lower, with NYSEDrug index ending the trading session at 297.91, which represents -0.64% versus the previous tradings session close. The Drug index had widespread weakness with 3 out of 15 components trading higher.

The sector's top performer today was GlaxoSmithKline (NYSE:GSK) closing the tradingsession at $39.42 representing 0.84%. versus the previous trading session price action. GlaxoSmithKline, the U.K. based pharmaceutical and health related consumer products maker, shares have defined support at $38.47 and resistance at $40.99.

Teva (NASDAQ:TEVA) was also among the top performers, closing the trading session at $50.69 representing 0.64% from its previous close. Teva, the largest generic drug maker in the world has calculated support and resistance levels at $49.86 and $55.74 respectively. The other top performer was (), which closed the trading session at $14.17 representing 0.14% from the previous trading session.

The sector's worst performer today was Novo Nordisk (NYSE:NVO) that closed the trading session at $102.55 or -1.86% from the previous close. Novo Nordisk, the Denmark based biopharmaceutical company focused on diabetes care shares have defined support at $89.87 and resistance at $105.97. Also among the worst performers was JNJ(NYSE:JNJ), which closed the trading session at $62.3 representing -1.56% from the previous trading session.